Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study.
Eur J Nucl Med Mol Imaging
; 50(12): 3777-3789, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37462775
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostate-Specific Antigen
/
Prostatic Neoplasms, Castration-Resistant
Type of study:
Prognostic_studies
Limits:
Aged
/
Humans
/
Male
Language:
En
Journal:
Eur J Nucl Med Mol Imaging
Journal subject:
MEDICINA NUCLEAR
Year:
2023
Document type:
Article
Affiliation country:
India
Country of publication:
Alemania